3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
INDUSTRY
6
OTHER
2
UNKNOWN
1
Study Type
Interventional
1
Sponsor
Conditions
Pain
2
Squamous Cell Carcinoma of Head and Neck
1
Neoplasms
1
Cancer Pain
1
Advanced Cancer
1
Interventions
pembrolizumab
1
nabiximols
1
apatinib
1
Sunitinib
1
Drug Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
UNKNOWN
×
Neoplasms
×
nabiximols
×
Clear all
NCT00530764
2013-06-20
SPRAY
GWPharm
Phase 2
Completed
360 enrolled
18 charts